Prediction of Drug–Polymer Miscibility through the use of Solubility Parameter based Flory–Huggins Interaction Parameter and the Experimental Validation: PEG as Model Polymer

2013/05/06 by Seema Thakral, Naveen K. Thakral · 25 citations
Chemistry · Materials Science · Pharmacology, Toxicology and Pharmaceutics · #Analytical Chemistry and Chromatography #Chemistry #Copolymer #Crystallization and Solubility Studies #Dispersion (optics) #Drug Solubulity and Delivery Systems #Flory–Huggins solution theory #Hildebrand solubility parameter #Materials science #Miscibility #Organic chemistry #Physics #Polymer #Polymer blend #Solubility #Thermodynamics

paper · doi:10.1002/jps.23583

openalex publication_date 2013/05/06 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Cited by

• Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory. [europepmc]
• Controlled Release from Zein Matrices: Interplay of Drug Hydrophobicity and pH. [europepmc]
• Prediction of Phase Behavior of Spray-Dried Amorphous Solid Dispersions: Assessment of Thermodynamic Models, Standard Screening Methods and a Novel Atomization Screening Device with Regard to Prediction Accuracy. [europepmc]
• Relative Contributions of Solubility and Mobility to the Stability of Amorphous Solid Dispersions of Poorly Soluble Drugs: A Molecular Dynamics Simulation Study. [europepmc]
• Engineering of Nanofibrous Amorphous and Crystalline Solid Dispersions for Oral Drug Delivery. [europepmc]
• Advances in coamorphous drug delivery systems. [europepmc]
• Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer Nanoparticles. [europepmc]
• Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component. [europepmc]
• Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions. [europepmc]
• Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. [europepmc]
• CHARMM-GUI Polymer Builder for Modeling and Simulation of Synthetic Polymers. [europepmc]
• Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. [europepmc]
• Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β Pathway. [europepmc]
• Impact of Matrix Surface Area on Griseofulvin Release from Extrudates Prepared via Nanoextrusion. [europepmc]
• Naproxen-Loaded Poly(2-hydroxyalkyl methacrylates): Preparation and Drug Release Dynamics. [europepmc]
• Challenges and Complications of Poly(lactic- co -glycolic acid)-Based Long-Acting Drug Product Development. [europepmc]
• Recent Fabrication Methods to Produce Polymer-Based Drug Delivery Matrices (Experimental and In Silico Approaches). [europepmc]
• Nanoseeded Desupersaturation and Dissolution Tests for Elucidating Supersaturation Maintenance in Amorphous Solid Dispersions. [europepmc]
• Selection of appropriate dapsone and poly(1-vinylpyrrolidone-co-vinyl acetate) ratios for the preparation of amorphous solid dispersions. [europepmc]
• Tyrosine-derived polymeric surfactant nanospheres insert cholesterol in cell membranes. [europepmc]
• Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening? [europepmc]
• Comparison of Two Grafted Copolymers, Soluplus and Kollicoat IR, as Solid Dispersion Carriers of Arteether for Oral Delivery Prepared by Different Solvent-Based Methods. [europepmc]
• Preparation of Hot-Melt-Extruded Solid Dispersion Based on Pre-Formulation Strategies and Its Enhanced Therapeutic Efficacy. [europepmc]
• Predicting Drug Loading Capacity for PLA-Amorphous Drug System Using Hansen Solubility Parameters. [europepmc]
• Hot-Melt Processed Glibenclamide Glassy Solutions: A Novel Oral Delivery Platform for Enhanced Bioavailability in Diabetes. [europepmc]